Company / CapEx per Share
Denali Therapeutics Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.07
FY2025
5-year range
$0.03 / $0.15
FY2021-FY2025
Trend
-42.7%
vs FY2024
Sector context
#68 of 192
Health Care
What the data says
At $0.07, Denali Therapeutics Inc.'s capex per share ranks #68 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2022 to $0.95 in FY2016.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of +13.3%.
Declined from $0.10 to $0.07 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +37.6%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
#68 of 192 in Health CareTop 35% of 192This company $0.07 Sector average $2.46
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 42.7% year-over-year.
- Ranks #68 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -42.7% |
| FY2024 | $0.11 | +20.8% |
| FY2023 | $0.10 | +276.0% |
| FY2022 | $0.03 | -83.0% |
| FY2021 | $0.15 | +321.5% |
| FY2020 | $0.04 | +16.1% |
| FY2019 | $0.03 | -56.7% |
| FY2018 | $0.07 | -63.5% |
| FY2017 | $0.19 | -79.9% |
| FY2016 | $0.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026